Literature DB >> 19409121

T2-Weighted endorectal magnetic resonance imaging of prostate cancer after external beam radiation therapy.

Antonio C Westphalen1, John Kurhanewicz, Rui M G Cunha, I-Chow Hsu, John Kornak, Shoujun Zhao, Fergus V Coakley.   

Abstract

PURPOSE: To retrospectively determine the accuracy of T2-weighted endorectal MR imaging in the detection of prostate cancer after external beam radiation therapy and to investigate the relationship between imaging accuracy and time since therapy.
MATERIALS AND METHODS: Institutional review board approval was obtained and the study was HIPPA compliant. We identified 59 patients who underwent 1.5 Tesla endorectal MR imaging of the prostate between 1999 and 2006 after definitive external beam radiation therapy for biopsy-proven prostate cancer. Two readers recorded the presence or absence of tumor on T2-weighted images. Logistic regression and Fisher's exact tests for 2x2 tables were used to determine the accuracy of imaging and investigate if accuracy differed between those imaged within 3 years of therapy (n = 25) and those imaged more than 3 years after therapy (n = 34). Transrectal biopsy was used as the standard of reference for the presence or absence of recurrent cancer.
RESULTS: Thirty-four of 59 patients (58%) had recurrent prostate cancer detected on biopsy. The overall accuracy of T2-weighted MR imaging in the detection cancer after external beam radiation therapy was 63% (37/59) for reader 1 and 71% for reader 2 (42/59). For both readers, logistic regression showed no difference in accuracy between those imaged within 3 years of therapy and those imaged more than 3 years after therapy (p = 0.86 for reader 1 and 0.44 for reader 2).
CONCLUSION: T2-weighted endorectal MR imaging has low accuracy in the detection of prostate cancer after external beam radiation therapy, irrespective of the time since therapy.

Entities:  

Mesh:

Year:  2009        PMID: 19409121      PMCID: PMC4532331          DOI: 10.1590/s1677-55382009000200007

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


  23 in total

1.  Some issues in resolution of diagnostic tests using an imperfect gold standard.

Authors:  D M Hawkins; J A Garrett; B Stephenson
Journal:  Stat Med       Date:  2001-07-15       Impact factor: 2.373

Review 2.  Prostate specific antigen only progression of prostate cancer.

Authors:  J W Moul
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450

3.  Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial.

Authors:  Alan Pollack; Gunar K Zagars; John A Antolak; Deborah A Kuban; Isaac I Rosen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-11-01       Impact factor: 7.038

4.  Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology.

Authors:  A E Wefer; H Hricak; D B Vigneron; F V Coakley; Y Lu; J Wefer; U Mueller-Lisse; P R Carroll; J Kurhanewicz
Journal:  J Urol       Date:  2000-08       Impact factor: 7.450

5.  Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience.

Authors:  Darko Pucar; Amita Shukla-Dave; Hedvig Hricak; Chaya S Moskowitz; Kentaro Kuroiwa; Semra Olgac; Lanie E Ebora; Peter T Scardino; Jason A Koutcher; Kristen L Zakian
Journal:  Radiology       Date:  2005-06-21       Impact factor: 11.105

Review 6.  Population-based prostate cancer trends in the United States: patterns of change in the era of prostate-specific antigen.

Authors:  R A Stephenson; J L Stanford
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

7.  Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.

Authors:  Masoom A Haider; Peter Chung; Joan Sweet; Ants Toi; Kartik Jhaveri; Cynthia Ménard; Padraig Warde; John Trachtenberg; Gina Lockwood; Michael Milosevic
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-19       Impact factor: 7.038

8.  Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence.

Authors:  Darko Pucar; Hedvig Hricak; Amita Shukla-Dave; Kentaro Kuroiwa; Marija Drobnjak; James Eastham; Peter T Scardino; Michael J Zelefsky
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-01       Impact factor: 7.038

9.  Pathologic evidence of dose-response and dose-volume relationships for prostate cancer treated with combined external beam radiotherapy and high-dose-rate brachytherapy.

Authors:  Larry L Kestin; Neal S Goldstein; Frank A Vicini; Christina Mitchell; Gary S Gustafson; Jannifer S Stromberg; Peter Y Chen; Alvaro A Martinez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-09-01       Impact factor: 7.038

Review 10.  Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen.

Authors:  C Obek; P Louis; F Civantos; M S Soloway
Journal:  J Urol       Date:  1999-02       Impact factor: 7.450

View more
  15 in total

1.  CADOnc©: An Integrated Toolkit For Evaluating Radiation Therapy Related Changes In The Prostate Using Multiparametric MRI.

Authors:  Satish Viswanath; Pallavi Tiwari; Jonathan Chappelow; Robert Toth; John Kurhanewicz; Anant Madabhushi
Journal:  Proc IEEE Int Symp Biomed Imaging       Date:  2011-03

2.  Multiparametric 3T endorectal mri after external beam radiation therapy for prostate cancer.

Authors:  Antonio C Westphalen; Galen D Reed; Phillip P Vinh; Christopher Sotto; Daniel B Vigneron; John Kurhanewicz
Journal:  J Magn Reson Imaging       Date:  2012-04-25       Impact factor: 4.813

3.  Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrast-enhanced images.

Authors:  M Abd-Alazeez; N Ramachandran; N Dikaios; H U Ahmed; M Emberton; A Kirkham; M Arya; S Taylor; S Halligan; S Punwani
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-02-03       Impact factor: 5.554

Review 4.  Prostate MR Imaging for Posttreatment Evaluation and Recurrence.

Authors:  Sonia Gaur; Baris Turkbey
Journal:  Radiol Clin North Am       Date:  2017-11-27       Impact factor: 2.303

5.  Identifying Quantitative In Vivo Multi-Parametric MRI Features For Treatment Related Changes after Laser Interstitial Thermal Therapy of Prostate Cancer.

Authors:  Satish Viswanath; Robert Toth; Mirabela Rusu; Dan Sperling; Herbert Lepor; Jurgen Futterer; Anant Madabhushi
Journal:  Neurocomputing       Date:  2014-11-20       Impact factor: 5.719

6.  [Multiparametric prostate MRI for follow-up monitoring after radiation therapy].

Authors:  A M Weidner; D J Dinter; M Bohrer; M Sertdemir; D Hausmann; F Wenz; S O Schoenberg
Journal:  Radiologe       Date:  2012-03       Impact factor: 0.635

7.  Locally recurrent prostate cancer after external beam radiation therapy: diagnostic performance of 1.5-T endorectal MR imaging and MR spectroscopic imaging for detection.

Authors:  Antonio C Westphalen; Fergus V Coakley; Mack Roach; Charles E McCulloch; John Kurhanewicz
Journal:  Radiology       Date:  2010-06-15       Impact factor: 11.105

8.  Quantitative Evaluation of Treatment Related Changes on Multi-Parametric MRI after Laser Interstitial Thermal Therapy of Prostate Cancer.

Authors:  Satish Viswanath; Robert Toth; Mirabela Rusu; Dan Sperling; Herbert Lepor; Jurgen Futterer; Anant Madabhushi
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2013-03-15

Review 9.  Multiparametric Magnetic Resonance Imaging of Recurrent Prostate Cancer.

Authors:  Francesca V Mertan; Matthew D Greer; Sam Borofsky; Ismail M Kabakus; Maria J Merino; Bradford J Wood; Peter A Pinto; Peter L Choyke; Baris Turkbey
Journal:  Top Magn Reson Imaging       Date:  2016-06

10.  Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study.

Authors:  Elnasif Arrayeh; Antonio C Westphalen; John Kurhanewicz; Mack Roach; Adam J Jung; Peter R Carroll; Fergus V Coakley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-02-11       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.